---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-036995"
form_type: "8-K"
ticker: "SYRA"
cik: "0001922335"
company_name: "Syra Health Corp"
filed_at: "2026-08-11T12:37:15+00:00"
generated_at: "2026-08-11T12:40:10.939366+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Syra Health posts Q2 2026 profit of $250K, revenue up 23% YoY to $2.4M

## Summary
- Q2 2026 net income $250,242 vs net loss $(63,596) in Q2 2025; second consecutive profitable quarter.
- Revenue grew 23% YoY to $2.4M; gross margin expanded to 44.5%, a company record, up from 38.7%.
- EPS $0.02 vs $(0.01) loss; EBITDA turned positive at $253,200 vs $(53,760) in Q2 2025.
- Healthcare workforce revenue jumped 87% YoY to $678,113; population health rose 8% to $1.7M.
- Anticipates CMS ACCESS Model approval with HealthSync as potential 10-year revenue; cash $2.1M, no long-term debt.

## SEC filing metadata
- accession: 0001493152-26-036995
- form_type: 8-K
- ticker: SYRA
- cik: 0001922335
- company_name: Syra Health Corp
- filed_at: 2026-08-11T12:37:15+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1922335/000149315226036995/0001493152-26-036995-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1922335/000149315226036995/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-036995
- JSON: https://secwatch.observer/filing/0001493152-26-036995.json
- Plain text: https://secwatch.observer/filing/0001493152-26-036995.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.